組氨酸豐富糖蛋白(HRG)重組蛋白
Recombinant Histidine Rich Glycoprotein (HRG)
HPRG; HRGP; Histidine-Proline Rich Glycoprotein; Thrombophilia Due To Elevated HRG
- 編號URPC534Ra01
- 物種Rattus norvegicus (Rat，大鼠) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位分泌
- 預(yù)測分子量26.3kDa
- 實(shí)際分子量29kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Ile106~Pro302 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)7.3
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 576 ¥ 1440 ¥ 2880 ¥ 8640 ¥ 21600
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
SDS-PAGE圖
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UAPC534Ra61 | 組氨酸豐富糖蛋白(HRG)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPC534Ra01 | 組氨酸豐富糖蛋白(HRG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPC534Ra61 | 組氨酸豐富糖蛋白(HRG)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAC534Ra01 | 組氨酸豐富糖蛋白(HRG)多克隆抗體 | WB; IHC |
| UMAC534Ra21 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | WB; IHC |
| UMAC534Ra24 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | WB |
| UMAC534Ra25 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | WB |
| UMAC534Ra26 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | WB; IHC |
| UMAC534Ra27 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | WB; IHC |
| UMAC534Ra29 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | WB |
| UMAC534Ra22 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | WB; IHC |
| UMAC534Ra23 | 組氨酸豐富糖蛋白(HRG)單克隆抗體 | WB; IHC |
| UFAC534Ra02 | 抗組氨酸豐富糖蛋白(HRG)單克隆抗體 | FCM |
| USEC534Ra | 組氨酸豐富糖蛋白(HRG)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMC534Ra | 組氨酸豐富糖蛋白(HRG)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| J. Proteome Res. | Identification and Confirmation of Differentially Expressed Fucosylated Glycoproteins in the Serum of Ovarian Cancer Patients Using a Lectin Array and LC–MS/MS [ACS: pr300330z] |
| Medical Oncology | Evaluation of histidine-rich glycoprotein tissue RNA and serum protein as novel markers for breast cancer [Springer: Source] |
| Int J Cancer | The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine‐rich glycoprotein [PubMed: 25363753] |
| Nucleic Acid Therapeutics | Pharmacokinetic and Pharmacodynamic Investigations of ION-353382, a Model Antisense Oligonucleotide: Using Alpha-2-Macroglobulin and Murinoglobulin Double-Knockout Mice [Pubmed:27031383] |
| United States Patent Application | Compositions and Methods for Diagnosing Lung Cancer [y2016:0077095.html] |
| Hypertension?Research | Combination of serum histidine-rich glycoprotein and uterine artery Doppler to predict preeclampsia [Pubmed:29416108] |
| journal of histochemistry & cytochemistry | Ultrastructural Localization of Histidine-rich Glycoprotein in Skeletal Muscle Fibers: Colocalization With AMP Deaminase [Pubmed: 31880188] |
| DOKLADY BIOCHEMISTRY AND BIOPHYSICS | Personalized Approach to Determination of Histidine-Rich Glycoprotein and E-Cadherin in Supernatants of Immunocompetent Blood Cells and Breast Biopsy … [Pubmed: 32342301] |
留言咨詢
